Renaissance Capital
IPOs reach pre-bubble highs in 2013
The market for initial public offerings in the U.S. hit a high this year not seen since the tech bubble burst in the early 2000s, with more than 222 IPOs expected before the end of 2013.
The 6 offerings priced Dec. 11 brought the annual IPO total to 218, beating the post-bubble peak of 217 reached in 2004 and eclipsing the most recent high of 213 in 2007, according to Renaissance Capital.
Biotech IPOs back off after record highs
Biotech is "back to normal," with record revenues from initial public offerings falling away to a lackluster end of the year.
The sector managed to rack up $2.5 billion through 33 IPOs so far this year, a record take representing more than the previous 5 years’ IPOs combined, but the momentum dwindled away and "enthusiasm for the sector has vanished," according to market analysts at Renaissance Capital IPO Center.